Highlights
Nature Index: How the US tech industry is shaping the transition to green energy
20 March 2025Major investments to fuel AI’s power demands are not the only way big tech is having an influence.
Engineering: Electric Vehicle Market Slowly Edges Toward Solid-State Batteries
03 March 2025Companies are gradually overcoming technical challenges with batteries that offer longer driving range and safer operation.
C&EN: ‘Berkelocene’ puts exotic berkelium in a sandwich
28 February 2025Researchers find bonding surprises at the extreme end of organometallic chemistry.
Nature: Can this revolutionary plastics-recycling plant help solve the pollution crisis?
04 February 2025A world-first facility has a new way to break down ‘unrecyclable’ plastic waste.
C&EN: Slow proteins may contribute to many chronic diseases
04 December 2024Reactive oxygen species in cells cause proteins to link up through disulfide bonds, reducing their mobility.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Author Archives: benbaxter
The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The FDA has finally indicated it will approve the first biosimilar drug for the United States, years after Europe.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
